A new drug called Sovaldi has an 80 percent cure rate for certain types of Hepatitis C infection when taken in combination with a drug called ribavirin. That's good news for the approximately 3.2 million Americans with chronic Hepatitis C. The bad news is the drug costs $1,000 per pill, or about $84,000 for a course of treatment. [July 2014, 770 word article]